A single-arm, multicentre, open-label, phase III clinical trial to evaluate the safety and tolerability of prophylactic emicizumab in persons with haemophilia A (PwHA) with FVIII inhibitors (STASEY): interim analysis results - Jimenez-Yuste, V
Oral Abstract OC 60.3.Paper presented at: International Society on Thrombosis and Haemostasis (ISTH) Congress, Melbourne, Australia, July 6–10, 2019. (Res PractThrombHemost2019;3(1))